Prognosis SOMA: Antibiotics

Q: ما هي اللغات التي تدعم Prognosis SOMA: Antibiotics؟

Prognosis SOMA: Antibiotics هي مدعومة على اللغات English,French,Italian,Portuguese,Spanish

Free

1.0.1for iPhone, iPad

Medical Joyworks LLC

Developer

27/09/2017

Update Date

Medical

Category

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

لقطات الشاشة لـ Prognosis SOMA: Antibiotics

iPad

iPhone

About Prognosis SOMA: Antibiotics

Osteopathic physicians are further eligible to obtain up to 1.5 American Osteopathic Association (AOA) Category 1-B CME credits for completing all six cases, at a rate of 0.25 CME credits per case.

This series aims to encourage present and future healthcare providers to recognize the importance of antibiotic stewardship, while simultaneously analyzing the impact of technology-enhanced active learning on perceived and measured learning outcomes among medical students, interns, residents, fellows, and practicing providers.

Prognosis SOMA: Choosing Wisely - Antibiotics is funded by the AOA, and based on Medical Joyworks LLC's novel, interactive mobile medical education technology and A.T. Still University-School of Osteopathic Medicine in Arizona (ATSU-SOMA)'s peer-reviewed material.

The project is headed by Joy H. Lewis, DO, PhD, FACP, principal investigator at ATSU-SOMA.